Nationwide Fund Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-6,873
| Closed | -$130K | – | 3340 |
|
2016
Q1 | $130K | Buy |
6,873
+1,995
| +41% | +$37.7K | ﹤0.01% | 2719 |
|
2015
Q4 | $130K | Buy |
4,878
+112
| +2% | +$2.99K | ﹤0.01% | 2747 |
|
2015
Q3 | $217K | Hold |
4,766
| – | – | ﹤0.01% | 2524 |
|
2015
Q2 | $153K | Sell |
4,766
-774
| -14% | -$24.8K | ﹤0.01% | 2855 |
|
2015
Q1 | $176K | Sell |
5,540
-285
| -5% | -$9.05K | ﹤0.01% | 2758 |
|
2014
Q4 | $220K | Hold |
5,825
| – | – | ﹤0.01% | 2583 |
|
2014
Q3 | $154K | Buy |
5,825
+83
| +1% | +$2.19K | ﹤0.01% | 2817 |
|
2014
Q2 | $170K | Buy |
5,742
+1,062
| +23% | +$31.4K | ﹤0.01% | 2828 |
|
2014
Q1 | $173K | Hold |
4,680
| – | – | ﹤0.01% | 2546 |
|
2013
Q4 | $194K | Sell |
4,680
-67
| -1% | -$2.78K | ﹤0.01% | 2704 |
|
2013
Q3 | $252K | Buy |
4,747
+500
| +12% | +$26.5K | ﹤0.01% | 2551 |
|
2013
Q2 | $227K | Buy |
+4,247
| New | +$227K | ﹤0.01% | 2432 |
|